Advances in Mass Spectrometry Within Drug Discovery

Journal of Biomolecular Screening

Volumn 21, Issue 2, 2016, Pages 109-110

  Wingfield, Jonathan ^a   Wilson, Ian D ^b  

^a ASTRAZENECA   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DEVELOPMENT; DRUG TARGETING; EDITORIAL; ELECTROSPRAY MASS SPECTROMETRY; HIGH THROUGHPUT SCREENING; HUMAN; LASER DIODE THERMAL DESORPTION MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; WHOLE BODY AUTORADIOGRAPHY; CHEMISTRY; PROCEDURES;

DRUG;

DRUG DISCOVERY; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS;

EID: 84954546745     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057115623454     Document Type: Editorial

References (12)

1. Leveridge M., Collier L., Edge C., et al. A High-Throughput Screen to Identify LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease Using RapidFire Mass Spectrometry. J. Biomol. Screen. 2016, 21, 145-155.
2. Gordon L., Allen M., Artursson P., et al. Direct Measurement of Intracellular Compound Concentration by RapidFire Mass Spectrometry Offers Insights into Cell Permeability. J. Biomol. Screen. 2016, 21, 156-164.
3. Campuzano I., San Miguel T., Rowe T., et al. High-Throughput Mass Spectrometric Analysis of Covalent Protein-Inhibitor Adducts for the Discovery of Irreversible Inhibitors: A Complete Workflow. J. Biomol. Screen. 2016, 21, 136-144.
4. Haarhoff Z., Wagner A., Picard P., et al. Coupling Laser Diode Thermal Desorption with Acoustic Sample Deposition to Improve Throughput of Mass Spectrometry-Based Screening. J. Biomol. Screen. 2016, 21, 165-175.
5. Haslam C., Hellicar J., Dunn A., et al. The Evolution of MALDI-TOF Mass Spectrometry toward Ultra-High-Throughput Screening: 1536-Well Format and Beyond. J. Biomol. Screen. 2016, 21, 176-186.
6. Song X., Zhang J., Chen X., et al. Identification of DGAT2 Inhibitors Using Mass Spectrometry. J. Biomol. Screen. 2016, 21, 117-126.
7. Hopcroft P., Fisher D., Development of a Medium-Throughput Targeted LCMS Assay to Detect Endogenous Cellular Levels of Malonyl-CoA to Screen Fatty Acid Synthase Inhibitors. J. Biomol. Screen. 2016, 21, 111-116.
8. Krishnamoorthy J., Otvos R., Kool J., et al. Microfluidic Chip-Based Online Screening Coupled to Mass Spectrometry: Identification of Inhibitors of Thrombin and Factor Xa. J. Biomol. Screen. 2016, 21, 212-220.
9. Yang B., Feng Y. J., Vu H., et al. Bioaffinity Mass Spectrometry Screening. J. Biomol. Screen. 2016, 21, 194-200.
10. Tang H., Duggan S., Richardson P. L., et al. Target Identification of Compounds from a Cell Viability Phenotypic Screen Using a Bead/Lysate-Based Affinity Capture Platform. J. Biomol. Screen. 2016, 21, 201-211.
11. Song J., Liu X., Tootoonchi M., et al. Polypharmacology of Small-Molecule Modulators of the 5-Lipoxygenase Activating Protein (FLAP) Observed via a High-Throughput Lipidomics Platform. J. Biomol. Screen. 2016, 21, 127-135.
12. Goodwin R., Nilsson A., Mackay L., et al. Exemplifying the Screening Power of Mass Spectrometry Imaging over Label-Based Technologies for Simultaneous Monitoring of Drug and Metabolite Distributions in Tissue Sections. J. Biomol. Screen. 2016, 21, 187-193.